AveXis to Present AVXS-101 Data at the Annual Meeting of the American Academy of Neurology
AVEXIS (AVXS)
Last avexis earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.avexis.com
Company Research
Source: GlobeNewswire
CHICAGO, April 19, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced that initial results from the pivotal study (STR1VE) of AveXis’ proprietary gene therapy, AVXS-101, for the treatment of spinal muscular atrophy (SMA) Type 1, and 24-month follow-up data from the Phase 1 trial, will be presented at the 2018 Annual Meeting of the American Academy of Neurology (AAN) taking place April 21-27 in Los Angeles. “AVXS-101 Gene Replacement Therapy Pivotal Trial in SMA Type 1: Pivotal Study (STR1VE) Update,” will be presented during the Emerging Science Poster Session IV on April 25 at 11:30 a.m. – 7:00 p.m. PDT. John W. Day, MD, PhD, Professor, Neurology & Neurological Sciences Director, Stanford Neuromuscular Disorders Program, Stanford University Medical Center, will be available starting at 5:30 p.m. PDT. Four platform prese
Show less
Read more
Impact Snapshot
Event Time:
AVXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AVXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AVXS alerts
High impacting AVEXIS news events
Weekly update
A roundup of the hottest topics